Beckwith-Wiedemann Syndrome Clinical Pathway — N/IICU
Beckwith-Wiedemann Syndrome Clinical Pathway — N/IICU
Patient Cohort
This pathway guides the care of neonates/infants born at the CHOP SDU or referred from outside institutions for further evaluation and treatment with overgrowth features such as giant omphalocele and/or constellation of findings suspicious for BWS.
Beckwith-Wiedemann Syndrome (BWS) is a human genomic imprinting disorder with much phenotypic variability. Variable phenotypes might include:
- Macrosomia
- Lateralized overgrowth
- Macroglossia
- Abdominal wall defects
- Neonatal hypoglycemia
- Predisposition to embryonal tumours1
BWS is caused mainly by epigenetic or genetic changes in the chromosome 11p15.5 region.1
BWS Clinical Features (use .bwschart to score)
Cardinal Features 2 pts for each feature |
Suggestive Features 1 pt for each feature |
---|---|
|
|